Clinical Trials Directory

Trials / Completed

CompletedNCT02926131

A Study to Evaluate a New Jaundice Stick Test

Field Evaluation of a Point-Of-Care Test for Serum Bilirubin Levels in Infants Born in a Tropical Limited-resource Setting.

Status
Completed
Phase
Study type
Observational
Enrollment
180 (actual)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
1 Day – 28 Days
Healthy volunteers
Accepted

Summary

This is an observational prospective study. The main purpose is to evaluate the stability of the Bilistick system in a humid and hot climate compared to the quantitative test for serum bilirubin (SBR) measurement currently used, the BR-501 total bilirubin meter, kept in a controlled environment. The secondary aim is to assess the operational feasibility of the Bilistick system in a tropical limited-resource setting, when used by locally trained nurses.

Detailed description

Study procedure: 1. SBR will be measured in parallel with two tests during three distinct seasons. (Cold, hot, rainy). The Blood is from an extra capillary sample taken from a single heel prick done for routine SBR) BR-501 total bilirubin meter, the quantitative test for SBR currently used, will be kept in a controlled environment while the new bilirubin test (Bilistick system) will be exposed to tropical conditions. 2. Trained nurses will use the Bilistick system observed by a qualified laboratory technician; Usability of the Bilistick system by the trained nurses will be evaluated via a 5-point Likert scale questionnaire and focus groups discussions.

Conditions

Interventions

TypeNameDescription
OTHERBlood sampling* One full capillary tube (50µl blood) will be used to measure the Hct level and the routine SBR using the BR-501 bilirubin meter machine (non-study procedure). * An additional half- filled capillary tube (25µl blood) will be used for the SBR measurement with the Bilistick system

Timeline

Start date
2017-01-25
Primary completion
2017-12-11
Completion
2017-12-11
First posted
2016-10-06
Last updated
2018-10-02

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02926131. Inclusion in this directory is not an endorsement.